By Dr. Youngran ParkInhibition of Histone methyltransferase for fighting endometriosis
By Dr. Youngran Park
Although the histone methyltransferase EZH2 and its product H3K27me3 are well studied in cancer, little is known about their role and potential as therapeutic targets in endometriosis. It has been previously reported that the endometriotic lesions are characterized by global…
Key Points Lay Summary